This Activity is supported by educational grants from Novartis Pharmaceuticals and Otsuka America Pharmaceutical, Inc.

The Burst CME™ format is an online, on-demand video program designed to deliver concise modular education. In this 6-part series, faculty experts Jonathan Barratt, PhD, FRCP; and Richard Lafayette, MD; work through the rapidly expanding treatment landscape for immunoglobulin A nephropathy (IgAN). Across the series, learners revisit the 4-hit pathophysiology of IgAN and examine the mechanisms of action and data on efficacy and safety for new and emerging therapeutic classes. Faculty also provide patient cases illustrating best practices in IgAN management.